Drug information for PRIFTIN

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET; ORAL 150MG Prescription  (Reference Drug) RIFAPENTINE rifapentine SANOFI AVENTIS US 21024
2010-08-09 Letter
2010-07-30 Label
2009-06-03 Label
2009-06-02 Letter
2000-10-20 Letter
2000-10-20 Label
2000-10-20 Review
1998-06-22 Letter
1998-06-22 Review
1998-06-22 Label

Drug Adverse Effects information for PRIFTIN

Role code Indications Reaction # Reports
PS MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE ARTHRALGIA 2
PS MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE CHILLS 2
PS MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE DIARRHOEA 2
PS MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE DYSPNOEA 2
PS MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE HEADACHE 2
PS MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE INFLUENZA 2
PS MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE NAUSEA 2
PS MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE PAIN 2
PS MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE PYREXIA 2
PS MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE VOMITING 2
Ads by Google